Investors Hangout Stock Message Boards Logo
  • Home
  • Mailbox
  • Boards
  • Favorites
  • Whats Hot!
  • Login - Join Now!
Innovation Pharmaceuticals IPIX
(Total Views: 218)
Posted On: 06/06/2017 12:52:34 PM
Post# of 72446
Avatar
Posted By: Drano
Another ASCO report: Dendreon's Provenge increases prostate cancer survival, ESPECIALLY when used in combination therapy.

http://www.fiercepharma.com/pharma/dendreon-t...ZTY1In0%3D

It galls me that they talk about how part of Dendreon's problem was a "delay" by the FDA. It was not a delay. It was a REJECTION of their drug, against the vote of the review panel, because one of the people on the final review panel was working on a rival drug himself. It took the involvement of senators and congressmen (after prospective patients organized and fought a PR campaign) to get the FDA to review the decision and then approve the drug.

So people died sooner than they could have, because one selfish doctor was stupidly allowed to be on a panel reviewing his rival's drug.

And, his drug never made it to the point of being reviewed by the FDA. And, of course, he was not sanctioned for this unconscionable and probably illegal behavior. At least, I sure HOPE something like that is illegal.














(4)
(0)









  • New Post - Investors HangoutNew Post

  • Public Reply - Investors HangoutPublic Reply

  • Private Reply - Investors HangoutPrivate Reply

  • Board - Investors HangoutBoard

  • More - Investors HangoutMore

  • Keep Post - Investors HangoutKeep Post
  • Report Post - Investors HangoutReport Post
  • Home - Investors HangoutHome
  • Mailbox - Investors HangoutMailbox
  • Boards - Investors HangoutBoards
  • Favorites - Investors HangoutFavorites
  • Whats Hot! - Investors HangoutWhats Hot!
  • Settings - Investors HangoutSettings
  • Login - Investors HangoutLogin
  • Live Site - Investors HangoutLive Site